✦ LIBER ✦

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer: McGuire W.P.; Hoskins W.J.; Brady M.F.; Kucera P.R.; Partridge E.E.; Look K.Y.; Clarke-Pearson D.L.; Davidson M. USA New Engl. J. Med. 1996 334/1 (1–6)

Book ID: 118893753
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 121 KB
Volume: 54
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(96)89727-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

McGuire WP, Hoskins WJ, Brady MF, Kucera

McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M, ,L'association paclitaxel-cisplatine augmente significativement la survie des patients porteurs d'un cancer de l'ovaire avancé Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 (1996) 1 6.

✍ Antoine Adenis 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 122 KB

Cyclophosphamide and Cisplatin Compared

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

✍ McGuire, William P.; Hoskins, William J.; Brady, Mark F.; Kucera, Paul R.; Partr 📂 Article 📅 1996 🏛 Massachusetts Medical Society 🌐 English ⚖ 123 KB